G Lawrence Thatcher

Suggest Changes
Learn More
BACKGROUND AND PURPOSE Chlormethiazole (CMZ), a clinical sedative/anxiolytic agent, did not reach clinical efficacy in stroke trials despite neuroprotection demonstrated in numerous animal models.(More)
  • 1